Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8920 | 1137 | 30.6 | 63% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CA 242 | Author keyword | 6 | 36% | 1% | 13 |
2 | PREOPERATIVE CEA LEVEL | Author keyword | 4 | 75% | 0% | 3 |
3 | POSTOPERATIVE SURVEILLANCE | Author keyword | 4 | 36% | 1% | 8 |
4 | SYNCHRONOUS ADENOMA | Author keyword | 3 | 60% | 0% | 3 |
5 | METACHRONOUS COLORECTAL CANCER | Author keyword | 2 | 44% | 0% | 4 |
6 | CARBOHYDRATE ANTIGEN 242 | Author keyword | 2 | 67% | 0% | 2 |
7 | DIGEST TUMOUR REGISTRY CALVADOS | Address | 2 | 67% | 0% | 2 |
8 | OCCULT HEPATIC METASTASES | Author keyword | 2 | 67% | 0% | 2 |
9 | PHYSICIAN AGE | Author keyword | 2 | 67% | 0% | 2 |
10 | RISK ADAPTED FOLLOW UP | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CA 242 | 6 | 36% | 1% | 13 | Search CA+242 | Search CA+242 |
2 | PREOPERATIVE CEA LEVEL | 4 | 75% | 0% | 3 | Search PREOPERATIVE+CEA+LEVEL | Search PREOPERATIVE+CEA+LEVEL |
3 | POSTOPERATIVE SURVEILLANCE | 4 | 36% | 1% | 8 | Search POSTOPERATIVE+SURVEILLANCE | Search POSTOPERATIVE+SURVEILLANCE |
4 | SYNCHRONOUS ADENOMA | 3 | 60% | 0% | 3 | Search SYNCHRONOUS+ADENOMA | Search SYNCHRONOUS+ADENOMA |
5 | METACHRONOUS COLORECTAL CANCER | 2 | 44% | 0% | 4 | Search METACHRONOUS+COLORECTAL+CANCER | Search METACHRONOUS+COLORECTAL+CANCER |
6 | CARBOHYDRATE ANTIGEN 242 | 2 | 67% | 0% | 2 | Search CARBOHYDRATE+ANTIGEN+242 | Search CARBOHYDRATE+ANTIGEN+242 |
7 | OCCULT HEPATIC METASTASES | 2 | 67% | 0% | 2 | Search OCCULT+HEPATIC+METASTASES | Search OCCULT+HEPATIC+METASTASES |
8 | PHYSICIAN AGE | 2 | 67% | 0% | 2 | Search PHYSICIAN+AGE | Search PHYSICIAN+AGE |
9 | RISK ADAPTED FOLLOW UP | 2 | 67% | 0% | 2 | Search RISK+ADAPTED+FOLLOW+UP | Search RISK+ADAPTED+FOLLOW+UP |
10 | EGTM | 2 | 50% | 0% | 3 | Search EGTM | Search EGTM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASMA CEA | 27 | 92% | 1% | 11 |
2 | POSTOPERATIVE SURVEILLANCE | 23 | 54% | 3% | 30 |
3 | RADICAL SURGERY | 14 | 13% | 9% | 99 |
4 | CEA | 12 | 10% | 10% | 115 |
5 | CEA LEVELS | 12 | 45% | 2% | 20 |
6 | CA 242 | 10 | 44% | 2% | 18 |
7 | CARCINOEMBRYONIC ANTIGEN LEVEL | 6 | 37% | 1% | 13 |
8 | MULTIPLE ADENOCARCINOMAS | 6 | 100% | 0% | 4 |
9 | SYNCHRONOUS CARCINOMA | 5 | 60% | 1% | 6 |
10 | SERUM CARCINOEMBRYONIC ANTIGEN | 5 | 21% | 2% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis | 2015 | 3 | 35 | 74% |
Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer | 2009 | 76 | 51 | 69% |
Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? | 2001 | 212 | 39 | 49% |
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials | 2002 | 260 | 29 | 52% |
Follow-up strategies for patients treated for non-metastatic colorectal cancer | 2007 | 83 | 47 | 77% |
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer | 2005 | 132 | 129 | 67% |
Surveillance After Colorectal Cancer Resection: A Systematic Review | 2011 | 13 | 51 | 84% |
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update | 2014 | 18 | 121 | 23% |
Optimal Post-Treatment Surveillance in Cancer Survivors: Is More Really Better? | 2015 | 1 | 57 | 35% |
Surveillance after colorectal cancer resection | 2000 | 67 | 37 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIGEST TUMOUR REGISTRY CALVADOS | 2 | 67% | 0.2% | 2 |
2 | CENT ISOTOP | 1 | 50% | 0.2% | 2 |
3 | INSERM U1086 | 1 | 50% | 0.2% | 2 |
4 | THOMAYER TEACHING HOSP | 1 | 40% | 0.2% | 2 |
5 | SERV CHIRURG DIGEST A | 1 | 25% | 0.3% | 3 |
6 | EPI 0106 | 1 | 33% | 0.2% | 2 |
7 | REGISTRE TUMEURS | 1 | 33% | 0.2% | 2 |
8 | AFDELING MAAG DARM LEVERZIEKTEN | 1 | 50% | 0.1% | 1 |
9 | CLIN INT MED 2 | 1 | 50% | 0.1% | 1 |
10 | CONSEJERIA SALUD BIENESTAR SOCIAL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204780 | CA 19 9//CA19 9//SPAN 1 |
2 | 0.0000124698 | CEACAM1//BILIARY GLYCOPROTEIN//CD66A |
3 | 0.0000112048 | CA 15 3//CA 153//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN |
4 | 0.0000108084 | ATSUCHI MEM RADIOL//HAMAMATSU MED IMAGING//PET ANGIOGRAPHY |
5 | 0.0000098506 | SURVIVORSHIP CARE PLANS//SURVIVORSHIP CARE PLAN//TREATMENT SUMMARIES |
6 | 0.0000089760 | ENDORECTAL ULTRASOUND//RECTUM NEOPLASMS//ENDORECTAL ULTRASONOGRAPHY |
7 | 0.0000083018 | OCCULT NEOPLASTIC CELLS//COMPLETE MESOCOLIC EXCISION//LYMPH NODE YIELD |
8 | 0.0000081932 | COLORECTAL LIVER METASTASES//LIVER METASTASES//LIVER RESECTION |
9 | 0.0000076823 | PELVIC EXENTERATION//RECURRENT RECTAL CANCER//LOCALLY RECURRENT RECTAL CANCER |
10 | 0.0000068947 | FECAL BLOOD//NURSE ENDOSCOPIST//FECAL OCCULT BLOOD |